Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-23-000627
Filing Date
2023-02-10
Accepted
2023-02-10 16:14:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 versor-atrs123122a1.htm SC 13G/A 53391
  Complete submission text file 0001172661-23-000627.txt   55397
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Subject) CIK: 0001016169 (see all company filings)

EIN.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-47575 | Film No.: 23612000
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 1120 AVENUE OF THE AMERICAS 15 FL NEW YORK NY 10036
Business Address 1120 AVENUE OF THE AMERICAS 15 FL NEW YORK NY 10036 212.626.6508
Versor Investments LP (Filed by) CIK: 0001650301 (see all company filings)

EIN.: 464720267 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A